Literature DB >> 16458302

The muO-conotoxin MrVIA inhibits voltage-gated sodium channels by associating with domain-3.

Stefan Zorn1, Enrico Leipold, Alfred Hansel, Grzegorz Bulaj, Baldomero M Olivera, Heinrich Terlau, Stefan H Heinemann.   

Abstract

Several families of peptide toxins from cone snails affect voltage-gated sodium (Na(V)) channels: mu-conotoxins block the pore, delta-conotoxins inhibit channel inactivation, and muO-conotoxins inhibit Na(V) channels by an unknown mechanism. The only currently known muO-conotoxins MrVIA and MrVIB from Conus marmoreus were applied to cloned rat skeletal muscle (Na(V)1.4) and brain (Na(V)1.2) sodium channels in mammalian cells. A systematic domain-swapping strategy identified the C-terminal pore loop of domain-3 as the major determinant for Na(V)1.4 being more potently blocked than Na(V)1.2 channels. muO-conotoxins therefore show an interaction pattern with Na(V) channels that is clearly different from the related mu- and delta-conotoxins, indicative of a distinct molecular mechanism of channel inhibition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458302     DOI: 10.1016/j.febslet.2006.01.057

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

Review 1.  Sodium channels and pain: from toxins to therapies.

Authors:  Fernanda C Cardoso; Richard J Lewis
Journal:  Br J Pharmacol       Date:  2017-09-02       Impact factor: 8.739

Review 2.  Animal toxins influence voltage-gated sodium channel function.

Authors:  John Gilchrist; Baldomero M Olivera; Frank Bosmans
Journal:  Handb Exp Pharmacol       Date:  2014

3.  Development of a μO-Conotoxin Analogue with Improved Lipid Membrane Interactions and Potency for the Analgesic Sodium Channel NaV1.8.

Authors:  Jennifer R Deuis; Zoltan Dekan; Marco C Inserra; Tzong-Hsien Lee; Marie-Isabel Aguilar; David J Craik; Richard J Lewis; Paul F Alewood; Mehdi Mobli; Christina I Schroeder; Sónia Troeira Henriques; Irina Vetter
Journal:  J Biol Chem       Date:  2016-03-29       Impact factor: 5.157

4.  Biophysical properties of Na(v) 1.8/Na(v) 1.2 chimeras and inhibition by µO-conotoxin MrVIB.

Authors:  O Knapp; S T Nevin; T Yasuda; N Lawrence; R J Lewis; D J Adams
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

5.  A diverse family of novel peptide toxins from an unusual cone snail, Conus californicus.

Authors:  W F Gilly; T A Richmond; T F Duda; C Elliger; Z Lebaric; J Schulz; J P Bingham; J V Sweedler
Journal:  J Exp Biol       Date:  2011-01-01       Impact factor: 3.312

6.  Navβ subunits modulate the inhibition of Nav1.8 by the analgesic gating modifier μO-conotoxin MrVIB.

Authors:  Michael J Wilson; Min-Min Zhang; Layla Azam; Baldomero M Olivera; Grzegorz Bulaj; Doju Yoshikami
Journal:  J Pharmacol Exp Ther       Date:  2011-05-17       Impact factor: 4.030

7.  Specificity, affinity and efficacy of iota-conotoxin RXIA, an agonist of voltage-gated sodium channels Na(V)1.2, 1.6 and 1.7.

Authors:  Brian Fiedler; Min-Min Zhang; Oga Buczek; Layla Azam; Grzegorz Bulaj; Raymond S Norton; Baldomero M Olivera; Doju Yoshikami
Journal:  Biochem Pharmacol       Date:  2008-04-06       Impact factor: 5.858

8.  Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes.

Authors:  Jonathan W Theile; Theodore R Cummins
Journal:  Front Pharmacol       Date:  2011-10-04       Impact factor: 5.810

9.  muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits.

Authors:  J Ekberg; A Jayamanne; C W Vaughan; S Aslan; L Thomas; J Mould; R Drinkwater; M D Baker; B Abrahamsen; J N Wood; D J Adams; M J Christie; R J Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

Review 10.  Conotoxins targeting neuronal voltage-gated sodium channel subtypes: potential analgesics?

Authors:  Oliver Knapp; Jeffrey R McArthur; David J Adams
Journal:  Toxins (Basel)       Date:  2012-11-08       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.